Analyst Ratings for Acorda Therapeutics Inc. (ACOR)

Updated: 2017-07-27

Shares of Acorda Therapeutics Inc. (NASDAQ:ACOR) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for ACOR last month.

8 analysts issued ratings on the stock, where 2 gave ACOR a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Many analysts weighed in on price targets for ACOR. The most optimistic analyst gave a price target of 35, implying a possible profit of 61.29 percent. The most pessimistic price target was 17, implying a possible loss of -21.66 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 3.15 percent. The average change in earnings estimates over the last 90 days is 75.62 percent. Meanwhile, fiscal year estimates have been revised upwards by 2.05 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 26.1 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 1 analysts have revised their quarterly estimates upwards in the past 30 days, while 2 analysts made negative revisions. During this time, 1 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 2 analysts that revised their FY estimates downwards.

In the trailing 52-weeks, ACOR hit 33.00 at the highest peak, while it's lowest trading point was 13.60. Currently the stock is 59.56 percent higher than its low, and below the high by 34.24 percent. ACOR has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The ACOR value stock report compares ACOR to some of its peers using value stock charts. The stock has a market capitalization of $1.05 billion. ACOR will post this quarters earnings in days, on 0000-00-00.